Khakzad Mohammad Reza, Mirsadraee Majid, Sankian Mojtaba, Varasteh Abdolreza, Meshkat Mojtaba
Zakaria Research Center, Islamic Azad University-Mashhad branch, Mashhad, Iran.
Iran J Allergy Asthma Immunol. 2009 Sep;8(3):155-60.
Spirometry has been used as a common diagnostic test in asthma. Most of the patients with a mild asthma have a FEV1 within normal range. Hence, other diagnostic methods are usually used. The aim of this study was to evaluate whether eosinophil Cationic Protein (ECP) could be an accurate diagnostic marker of mild asthma. In this study diagnosis of asthma was made according to internationally accepted criteria. Asthma severity was evaluated according to frequency of symptoms and FEV1.Adequate sputum samples were obtained in 50 untreated subjects. A control group of 12 normal subjects that showed PC20 more than 8 mg/dl was also examined. Sputum was induced by inhalation of hypertonic saline. Inflammatory cells in sputum smears were assessed semi-quantitatively. ECP and IgE concentrations, eosinophil (EO) percentage and ECP/EO ratio in serum and sputum were also determined. The results revealed that Cough and dyspnea were the most frequent clinical findings. Dyspnea and wheezing were the symptoms that correlated with staging of asthma. FEV1 was within normal range (more than 80% of predicted) in 22 (44%) subjects.Asthmatic patients showed significantly higher numbers of blood eosinophils (4.5+/- 3.1% vs. 1.2+/-0.2%, P=0.009), and higher levels of serum ECP than control group (3.1+/- 2.6 % and 22.6+/- 15.8 ng/ml, respectively). Sputum ECP level in asthmatics was significantly higher than non- asthmatics (55.3+/-29.8ng/mL vs. 25.0+/-24.7ng/mL, P=0.045). Regression analysis showed no significant correlation between spirometric parameters and biomarkers, the only exception was significant correlation between FEF(25-75) and serum ECP (r= 0.28, P 0.041). Regarding clinical symptoms, wheezing was significantly correlated with elevation of most of biomarkers. Since, serum and sputum ECP levels are elevated in untreated asthmatics, the ECP level could be used for accurate diagnosis of mild form of asthma in which spirometry is unremarkable.
肺量计已被用作哮喘的一种常见诊断测试。大多数轻度哮喘患者的第一秒用力呼气容积(FEV1)在正常范围内。因此,通常会使用其他诊断方法。本研究的目的是评估嗜酸性粒细胞阳离子蛋白(ECP)是否可以作为轻度哮喘的准确诊断标志物。在本研究中,哮喘的诊断依据国际公认的标准进行。根据症状出现频率和FEV1评估哮喘严重程度。在50名未经治疗的受试者中获取了足够的痰液样本。还检查了12名正常受试者组成的对照组,其气道激发试验浓度(PC20)超过8mg/dl。通过吸入高渗盐水诱导痰液。对痰液涂片中的炎症细胞进行半定量评估。还测定了血清和痰液中的ECP和免疫球蛋白E(IgE)浓度、嗜酸性粒细胞(EO)百分比以及ECP/EO比值。结果显示,咳嗽和呼吸困难是最常见的临床症状。呼吸困难和喘息是与哮喘分期相关的症状。22名(44%)受试者的FEV1在正常范围内(超过预测值的80%)。哮喘患者的血液嗜酸性粒细胞数量显著高于对照组(分别为4.5±3.1%和1.2±0.2%,P = 0.009),血清ECP水平也高于对照组(分别为3.1±2.6%和22.6±15.8ng/ml)。哮喘患者痰液中的ECP水平显著高于非哮喘患者(分别为55.3±29.8ng/mL和25.0±24.7ng/mL,P = 0.045)。回归分析显示肺量计参数与生物标志物之间无显著相关性,唯一的例外是用力呼气流量(25%-75%)(FEF(25-75))与血清ECP之间存在显著相关性(r = 0.28,P 0.041)。关于临床症状,喘息与大多数生物标志物的升高显著相关。由于未经治疗的哮喘患者血清和痰液中的ECP水平升高,因此ECP水平可用于准确诊断肺量计检查无明显异常的轻度哮喘。